Now, Leo Pharma can get properly started on launching the drug Adtralza in the EU.
Tuesday, the EU Commission ratified the former recommendation for approval, which the Committee for Medicinal Products for Human Use (CHMP) gave Adtralza in April, according to a press release from the company.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.